Arbetsbeskrivning

Position Summary

The Public Affairs & Communications lead, oncology will drive GSK Sweden’s external affairs and communications strategy to support the successful launch and access of GSK’s expanding oncology portfolio. The role will shape the policy environment, strengthen GSK’s position within Swedish cancer care, and ensure timely and sustainable patient access to innovative treatments.

In addition, the role will lead external communications activities for oncology, ensuring consistent, compliant, and impactful messaging across stakeholders and channels, and proactively influence the public narrative around cancer care and innovation.

Working closely with the Head of Government Affairs & Communications, the Oncology Business Unit, and cross-functional teams, the manager will translate portfolio needs into policy and communication strategies and build high-impact stakeholder partnerships.

We create a place where people can grow, be their best, be safe, and feel welcome, valued and included. We offer a competitive salary, an annual bonus based on company performance, healthcare and wellbeing programmes, pension plan membership, and shares and savings programme.

We embrace modern work practises; our Performance with Choice programme offers a hybrid working model, empowering you to find the optimal balance between remote and in-office work.

Responsibilities

• Execute priority areas of the Government Affairs strategy with a strong focus on oncology launches.
• Identify and analyse policy, regulatory, and healthcare trends impacting oncology access and innovation.
• Shape the external environment by engaging authorities, policymakers, industry partners, and cancer organisations at national and regional level.
• Develop and deliver compelling messages and narratives in media and public forums to position GSK as a trusted voice in oncology.
• Lead external communications for oncology, including media engagement, press materials, and alignment of messaging with compliance standards.
• Support brilliant launches by ensuring policy readiness, external narrative development, and stakeholder mapping.
• Build long-term partnerships with patient organisations and integrate patient perspectives into policy and communication activities.
• Provide timely intelligence on political, healthcare, and media developments affecting GSK’s oncology portfolio.

Why you?

Basic Qualifications & Skills:

We are looking for professionals with these required skills to achieve our goals:

• Experience in public affairs, healthcare policy, or related fields
• Strong understanding of the Swedish healthcare and political system
• Proven ability to build senior-level stakeholder relationships and manage media interactions.
• Demonstrated ability to craft persuasive messages and influence narratives in media and public debate.
• Ability to convert complex scientific and policy issues into clear strategies and compelling communication.

Preferred Qualifications & Skills:

Please note the following skills are not necessary, just preferred, if you do not have them, please still apply:

• Communications experience
• Oncology experience

Closing Date for Applications – 11 January 2026 (COB)

Please note: As we approach the holiday season, our recruitment team and hiring managers will have limited availability between now and early January. We encourage you to apply and will review all applications, however response times will be longer than usual, and interviews will be scheduled after the New Year. We appreciate your understanding and look forward to connecting soon!

Please take a copy of the Job Description, as this will not be available post closure of the advert.

When applying for this role, please use the ‘cover letter’ of the online application or your CV to describe how you meet the competencies for this role, as outlined in the job requirements above. The information that you have provided in your cover letter and CV will be used to assess your application.

GSK remains committed to achieving bold commercial ambitions for the future. By 2031, we aim to deliver £40 billion in annual sales, leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patients globally. Our Ahead Together strategy is centred on early intervention to prevent and alter the course of disease, thereby protecting people and supporting healthcare systems.

Our diverse portfolio consists of vaccines, specialty medicines, and general medicines.

Through continuous innovation and a dedicated focus on scientific and technical excellence, we strive to develop and launch new, groundbreaking treatments that address critical health challenges.